Inovio Pharma buy UBS Group AG
Start price
14.11.25
/
50%
€0.53
Target price
14.11.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.11.26. The prediction end date can be changed by UBS_Group_AG at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Inovio Pharma | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by UBS_Group_AG for this prediction
In the thread Inovio Pharma diskutieren
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
Ratings data for INO provided by MarketBeat